Acute Lymphoblastic Leukemia

ClinicalJuly 1, 2026

Mobile Health Intervention Trial for AYA Leukemia Adherence

A micro-randomized clinical trial is underway to assess a mobile health intervention aimed at improving oral chemotherapy adherence among adolescents and young adults with acute lymphoblastic leukemia.

Relevant assets

Relevant companies

Recent signals(4)

Inotuzumab Ozogamicin Combined with Chemotherapy Shows Promise in Acute Lymphoblastic Leukemia

Text Messaging Improves Adherence to Oral Chemotherapy in ALL Patients

Interfant-21 Study on Blinatumomab for Infants with KMT2A-rearranged ALL

Mobile Health Intervention Trial for AYA Leukemia Adherence

Upcoming catalysts

Therapeutic areas

Get signals before the market moves